home / United States / BioMarin Pharmaceutical

BioMarin Pharmaceutical Market Cap

$11.51 B

+67.11 M

NASDAQ:BMRN · April 15, 2025

Share price

$60.02

Enterprise Value

$10.88 B

Change (1-Year)

-29.8%

Global Rank

#1441

Country Rank

#547

Regions

USA

Market cap

As of April 15, 2025, BioMarin Pharmaceutical (BMRN) has a market cap of $11.51 billion USD. According to our data, BioMarin Pharmaceutical is ranked No.1441 in global market value.

Sector Rank:

Biotech #64 Pharmaceuticals #60

BMRN Market Capitalization Growth

1 Years Growth:

-29.8%

3 Years Growth:

-21.8%

5 Years Growth:

-28.7%

10 Years Growth:

-47.5%

15 Years Growth:

173.0%

20 Years Growth:

1082.5%

Total Growth:

389%

BioMarin Pharmaceutical Market Cap Chart

YTD

10Y

15Y

20Y

MAX

BioMarin Pharmaceutical Market Cap CAGR Chart

BioMarin Pharmaceutical Market Cap History 1999 - 2025

Year	Market Cap	%Change
Apr 15, 2025	$11.51 B	-8.13%
Dec 31, 2024	$12.53 B	-31.83%
Dec 29, 2023	$18.38 B	-6.83%
Dec 30, 2022	$19.72 B	17.14%
Dec 31, 2021	$16.84 B	0.75%
Dec 31, 2020	$16.71 B	3.71%
Dec 31, 2019	$16.11 B	-0.70%
Dec 31, 2018	$16.23 B	-4.51%
Dec 29, 2017	$16.99 B	7.64%
Dec 30, 2016	$15.79 B	-20.92%
Dec 31, 2015	$19.97 B	15.88%
Dec 31, 2014	$17.23 B	28.50%
Dec 31, 2013	$13.41 B	42.99%
Dec 31, 2012	$9.38 B	43.11%
Dec 30, 2011	$6.55 B	27.66%
Dec 31, 2010	$5.13 B	43.17%
Dec 31, 2009	$3.58 B	5.67%
Dec 31, 2008	$3.39 B	-49.72%
Dec 31, 2007	$6.75 B	115.99%
Dec 29, 2006	$3.12 B	52.04%
Dec 30, 2005	$2.05 B	68.70%
Dec 31, 2004	$1.22 B	-17.65%
Dec 31, 2003	$1.48 B	10.07%
Dec 31, 2002	$1.34 B	-47.54%
Dec 31, 2001	$2.56 B	38.74%
Dec 29, 2000	$1.85 B	-17.55%
Dec 31, 1999	$2.24 B	100%

Similar Companies to BioMarin Pharmaceutical

Name	Market Cap	Market cap difference	Regions
Amgen AMGN	$158.77 B	0.132 B	USA
Sanofi SNY	$123.58 B	-0.002 M	France
Vertex Pharmaceuticals VRTX	$128.67 B	-0.003 M	USA
Regeneron Pharmaceuticals REGN	$60.99 B	1.014 B	USA
Pfizer PFE	$127.27 B	-0.003 M	USA
Bristol-Myers Squibb BMY	$101.74 B	-0.001 M	USA
Gilead Sciences GILD	$131.74 B	-0.002 M	USA
Novo Nordisk NVO	$286.98 B	70.023 B	Denmark
Merck MRK	$197.26 B	0.003 M	USA
Eli Lilly LLY	$679.94 B	-0.022 M	USA
Moderna MRNA	$10.14 B	-0.001 M	USA
Biogen BIIB	$17.12 B	0.000 M	USA

About BioMarin Pharmaceutical Inc.

Name

BioMarin Pharmaceutical Inc.

Website

https://www.biomarin.com

Headquarters

San Rafael,CA

symbol

BMRN

CURRENCY

USD

country

United States

fullTimeEmployees

3040

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

BMRN Market Cap Formula

Market Cap	=	BMRN Stock Price	*	BMRN Shares Outstanding
	=	$60.02	*	0.19 B
	=	$11.51 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe